Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -96.89% is 31% above its 5-year average of -140.97%, near the high end of its 5-year range (-211.62%–-64.13%).
3.02% above its 12-month average of -99.91%.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-06-30): -135.81%.
NET PROFIT MARGIN
-96.89%
NET PROFIT MARGIN AVG TTM
-99.91%
NET PROFIT MARGIN AVG 3Y
-140.74%
NET PROFIT MARGIN AVG 5Y
-140.97%
NET PROFIT MARGIN AVG 10Y
-79.75%
NET PROFIT MARGIN AVG 15Y
-76.88%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3.02%
CURRENT VS 3Y AVG
+31.16%
CURRENT VS 5Y AVG
+31.27%
CURRENT VS 10Y AVG
-21.49%
CURRENT VS 15Y AVG
-26.03%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 525 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Enanta Pharmaceuticals, Inc.
Market Cap
$365.95M
Net Profit Margin
-96.89%
TTM Avg
-99.91%
3Y Avg
-140.74%
5Y Avg
-140.97%
Market Cap
$360.92M
Net Profit Margin
-5.49%
TTM Avg
-11.37%
3Y Avg
-410.78%
5Y Avg
-2049.25%
Market Cap
$359.16M
Net Profit Margin
-1091.82%
TTM Avg
-436.37%
3Y Avg
-220.06%
5Y Avg
-1750.93%
Market Cap
$376.01M
Net Profit Margin
-81.04%
TTM Avg
-157.37%
3Y Avg
-379.90%
5Y Avg
-317.33%
Market Cap
$380.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-102.82%
5Y Avg
-175.43%
Market Cap
$352.29M
Net Profit Margin
69.34%
TTM Avg
-109.76%
3Y Avg
-150.31%
5Y Avg
-135.75%
Market Cap
$348.85M
Net Profit Margin
8.59%
TTM Avg
7.90%
3Y Avg
10.47%
5Y Avg
19.48%
Market Cap
$348.63M
Net Profit Margin
-81.76%
TTM Avg
-64.66%
3Y Avg
-75.38%
5Y Avg
-73.80%
Market Cap
$341.86M
Net Profit Margin
0.00%
TTM Avg
-11651.99%
3Y Avg
-6142.69%
5Y Avg
-4693.07%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enanta Pharmaceuticals, Inc. (ENTA) | $365.95M | -96.89% | -99.91% | -140.74% | -140.97% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $360.92M | -5.49% | -11.37% | -410.78% | -2049.25% |
| Opus Genetics, Inc. (IRD)vs › | $359.16M | -1091.82% | -436.37% | -220.06% | -1750.93% |
| Canopy Growth Corporation (CGC)vs › | $376.01M | -81.04% | -157.37% | -379.90% | -317.33% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $380.88M | 0.00% | 0.00% | -102.82% | -175.43% |
| Agenus Inc. (AGEN)vs › | $352.29M | 69.34% | -109.76% | -150.31% | -135.75% |
| Embecta Corp. (EMBC)vs › | $348.85M | 8.59% | 7.90% | 10.47% | 19.48% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $348.63M | -81.76% | -64.66% | -75.38% | -73.80% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $341.86M | 0.00% | -11651.99% | -6142.69% | -4693.07% |
| Cabaletta Bio, Inc. (CABA)vs › | $336.71M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-130.7%
Net Profit Margin
-96.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -135.81% |
| 2026-03-31 | -76.29% |
| 2025-12-31 | -64.13% |
| 2025-09-30 | -123.64% |
| 2025-06-30 | -99.68% |
| 2025-03-31 | -151.71% |
| 2024-12-31 | -131.43% |
| 2024-09-30 | -197.32% |
| 2024-06-30 | -126.08% |
| 2024-03-31 | -182.70% |
| 2023-12-31 | -185.56% |
| 2023-09-30 | -148.46% |
| 2023-06-30 | -206.78% |
| 2023-03-31 | -211.62% |
| 2022-12-31 | -122.90% |
| 2022-09-30 | -129.68% |
| 2022-06-30 | -162.74% |
| 2022-03-31 | -179.48% |
| 2021-12-31 | -108.92% |
| 2021-09-30 | -104.34% |
| 2021-06-30 | -111.10% |
| 2021-03-31 | -109.50% |
| 2020-12-31 | -26.24% |
| 2020-09-30 | -124.16% |
| 2020-06-30 | -76.48% |
| 2020-03-31 | -21.74% |
| 2019-12-31 | 25.57% |
| 2019-09-30 | 17.91% |
| 2019-06-30 | 15.86% |
| 2019-03-31 | 10.46% |
| 2018-12-31 | 37.22% |
| 2018-09-30 | 40.80% |
| 2018-06-30 | 35.43% |
| 2018-03-31 | 28.50% |
| 2017-12-31 | 30.68% |
| 2017-09-30 | 48.08% |
| 2017-06-30 | -112.18% |
| 2017-03-31 | -60.19% |
| 2016-12-31 | -47.81% |
| 2016-09-30 | -14.03% |
| 2016-06-30 | -7.70% |
| 2016-03-31 | -12.65% |
| 2015-12-31 | 54.06% |
| 2015-09-30 | 40.32% |
| 2015-06-30 | 20.85% |
| 2015-03-31 | 50.12% |
| 2014-12-31 | 54.21% |
| 2014-09-30 | -191.20% |
| 2014-06-30 | 119.03% |
| 2014-03-31 | -240.88% |
| 2013-12-31 | -601.34% |
| 2013-09-30 | -329.36% |
| 2013-06-30 | -250.94% |
| 2013-03-31 | -313.46% |
| 2012-12-31 | 78.81% |
| 2012-09-30 | -218.08% |
| 2012-06-30 | -137.73% |
| 2012-03-31 | 87.82% |
| 2011-12-31 | -426.32% |
| 2011-09-30 | 0.00% |
